[go: up one dir, main page]

WO2003047629A3 - Traitement de maladies - Google Patents

Traitement de maladies Download PDF

Info

Publication number
WO2003047629A3
WO2003047629A3 PCT/GB2002/005394 GB0205394W WO03047629A3 WO 2003047629 A3 WO2003047629 A3 WO 2003047629A3 GB 0205394 W GB0205394 W GB 0205394W WO 03047629 A3 WO03047629 A3 WO 03047629A3
Authority
WO
WIPO (PCT)
Prior art keywords
individual
skin
treatment
administering
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2002/005394
Other languages
English (en)
Other versions
WO2003047629A2 (fr
Inventor
Rachid Tazi-Ahnini
Simon Ward
Michael Cork
Gorden Duff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Skincare Ltd
Original Assignee
Molecular Skincare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Skincare Ltd filed Critical Molecular Skincare Ltd
Priority to AU2002365654A priority Critical patent/AU2002365654A1/en
Publication of WO2003047629A2 publication Critical patent/WO2003047629A2/fr
Publication of WO2003047629A3 publication Critical patent/WO2003047629A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un procédé d'administration d'une molécule à un individu consistant (a) à mettre en oeuvre un agent pouvant réaliser la dégradation d'un composant de la barrière épidermique de l'individu, (b) à administrer cet agent à l'individu, et (c) à administrer la molécule à l'individu. Elle concerne plus spécifiquement l'utilisation de protéolyse, et d'autres processus de dégradation pour la réduction de la fonction de barrière épidermique, afin de réguler le passage d'agents à travers le stratum corneum, puis dans le corps d'un individu. Un timbre contenant un agent, ou les deux agents à la fois, constitue un mode avantageux de réalisation de l'invention.
PCT/GB2002/005394 2001-11-29 2002-11-29 Traitement de maladies Ceased WO2003047629A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002365654A AU2002365654A1 (en) 2001-11-29 2002-11-29 Treatment of diseases via the skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0128629.3 2001-11-29
GB0128629A GB0128629D0 (en) 2001-11-29 2001-11-29 Method

Publications (2)

Publication Number Publication Date
WO2003047629A2 WO2003047629A2 (fr) 2003-06-12
WO2003047629A3 true WO2003047629A3 (fr) 2003-08-28

Family

ID=9926699

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/005394 Ceased WO2003047629A2 (fr) 2001-11-29 2002-11-29 Traitement de maladies

Country Status (3)

Country Link
AU (1) AU2002365654A1 (fr)
GB (1) GB0128629D0 (fr)
WO (1) WO2003047629A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015144183A1 (fr) * 2014-03-26 2015-10-01 University Of Copenhagen Traitement de la dermatite de contact

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556218A1 (fr) * 1983-12-12 1985-06-14 Gerard Alain Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique
WO1990009809A1 (fr) * 1989-02-23 1990-09-07 University Of Utah Systeme de liberation percutanee d'un medicament
JPH0344310A (ja) * 1989-07-10 1991-02-26 Mareyoshi Sawaguchi マコモ及びその近縁類を含有する化粧品
WO1995000651A1 (fr) * 1993-06-18 1995-01-05 Astra Aktiebolag Enzyme chymotryptique de la couche cornee (eccc) recombinee
WO2001034111A1 (fr) * 1999-11-08 2001-05-17 The Procter & Gamble Company Compositions cosmetiques
WO2001087255A1 (fr) * 2000-05-16 2001-11-22 Pacific Corporation Composition d'application externe ameliorant la permeabilite de la peau aux ingredients actifs de la composition

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556218A1 (fr) * 1983-12-12 1985-06-14 Gerard Alain Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique
WO1990009809A1 (fr) * 1989-02-23 1990-09-07 University Of Utah Systeme de liberation percutanee d'un medicament
JPH0344310A (ja) * 1989-07-10 1991-02-26 Mareyoshi Sawaguchi マコモ及びその近縁類を含有する化粧品
WO1995000651A1 (fr) * 1993-06-18 1995-01-05 Astra Aktiebolag Enzyme chymotryptique de la couche cornee (eccc) recombinee
WO2001034111A1 (fr) * 1999-11-08 2001-05-17 The Procter & Gamble Company Compositions cosmetiques
WO2001087255A1 (fr) * 2000-05-16 2001-11-22 Pacific Corporation Composition d'application externe ameliorant la permeabilite de la peau aux ingredients actifs de la composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 015, no. 181 (C - 0830) 9 May 1991 (1991-05-09) *

Also Published As

Publication number Publication date
AU2002365654A1 (en) 2003-06-17
AU2002365654A8 (en) 2003-06-17
GB0128629D0 (en) 2002-01-23
WO2003047629A2 (fr) 2003-06-12

Similar Documents

Publication Publication Date Title
WO2004028570A3 (fr) Methode de traitement de l'acouphene severe
WO2000038626A3 (fr) Composition de substrat et procede d'utilisation associe, aux fins de sequestration de substances irritantes pour la peau
WO2005000161A3 (fr) Procedes et dispositifs d'occlusion d'une lumiere corporelle et/ou d'administration d'agents therapeutiques
WO2002056912A3 (fr) Methode de traitement du cancer
WO2002100390A3 (fr) Methode amelioree de traitement du syndrome des facteurs de risque de coronaropathie chez l'etre humain
NO20034684D0 (no) Innretning for administrering av midler gjennom stratum corcum
WO2007089454A3 (fr) Procédés pour améliorer des traitements pour la peau
WO2003096990A3 (fr) Cages proteiques pour l'administration d'agents therapeutiques et d'imagerie medicale
WO2003032815A3 (fr) Dispositif medical servant a mettre en place des pieces
WO2003099771A3 (fr) Derives de diaryle-uree utilises pour le traitement des maladies dependant des proteines kinases
IL166070A0 (en) Hot-melt tts for administering rotigotine
WO2002076472A3 (fr) Combinaisons pharmaceutiques destinees au traitement du cancer
WO2003084611A8 (fr) Depsipeptide pour la therapie du cancer du rein
WO2004046196A3 (fr) Compositions et techniques de traitement d'infections bacteriennes avec des complexes proteine-dalbavancine
WO2003062273A3 (fr) Traitement medical
WO2004098568A3 (fr) Forme posologique anti-abus administrable par voie transdermique
WO2004110151A8 (fr) Traitement du cancer au moyen de composes de vitamine d actifs associes a des agents et a des traitements radiotherapeutiques
WO2003011327A3 (fr) Secretine pour le traitement de l'asthme
WO2002060410A3 (fr) Methodes d'administration locale a liberation prolongee de medicaments visant a l'ablation de tissus non desires
SE0102147D0 (sv) New methods
DE60119976D1 (en) Thixotropes nasenspray
WO1994017792A3 (fr) Compositions et procedes d'administration transdermique de medicaments
WO2007047157A8 (fr) Dispositif chirurgical et procede pour effectuer une revascularisation en association avec l'administration d'une substance therapeutique au niveau d'un tissu
WO2003059250A3 (fr) Compositions et procedes de traitement de troubles de l'excitation sexuelle chez la femme a l'aide d'un peptide lie au gene de la calcitonine hydrophobe
WO2004007676A3 (fr) Therapie combinee servant a traiter des tumeurs

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP